Searchable abstracts of presentations at key conferences in endocrinology

ea0056p499 | Diabetes therapy | ECE2018

Metabolic effects of liraglutide in type 2 diabetic patients.

Muros Mariola Mendez , Portillo Cristobal Morales , Hermosilla Antonio Manuel Garrido , Septimo Vianney Magaly Santiago , Perez Antonio Perez , Margalet Victor Sanchez , Brocca Maria Asuncion Martinez

Objectives: Obesity and type 2 diabetes mellitus (DM2) are risk factors for non-alcoholic fatty liver disease (NAFLD). The main objective was to study the incidence of NAFLD using the Hepatic Steatosis Index (HSI) in obese patients with DM2. Secondary objectives were to analyse the effect of liraglutide over HSI, body mass index (BMI) and glycated hemoglobin (HbA1c).Methods: Retrospective observational study of obese type 2 diabetic patients treated with...

ea0049ep569 | Diabetes complications | ECE2017

Diabetic choroidopathy and renal function

Hermosilla Antonio Manuel Garrido , Muros Mariola Mendez , Portillo Cristobal Morales , Hernandez Tomas Martin , Rivera Natividad Gonzalez , Granda Maria Jesus Diaz , de la Rua Franch Enrique Rodriguez , Sanchez Estanislao Gutierrez

Objectives: Examine the relationship between choroidal thickness (CT) and renal function tests.Methods: Cross-sectional study with 42 eyes of 21 ocular treatment-naïve diabetic patients. Demographic and ocular data were analyzed as well as the following renal function tests: microalbuminuria, microalbumin/creatinine ratio and glomerular filtration rate (CKD-EPI and MDRD-4). Choroidal thickness was measured by swept-source ocular coherence tomography...